PFO
HQL

PMG Family Office’s abrdn Life Sciences Investors HQL Stock Holding History

PMG Family Office’s Portfolio HQL Stock Details HQL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$466K Buy
23,312
+251
+1% +$4.43K 0.43% 76
2026
Q1 		$375K Buy
23,061
+510
+2% +$8.52K 0.42% 75
2025
Q4 		$378K Sell
22,551
-85
-0.4% -$1.43K 0.44% 75
2025
Q3 		$351K Buy
+22,636
New +$310K 0.39% 79

Other funds holding HQL

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $13B AUM 71.84% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
NIM
Needham Investment Management New York $3.33B AUM 163.16% 1-Year Est. Return
FHA
Flagship Harbor Advisors Boston, Massachusetts $2.61B AUM 23.21% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.56B AUM 35.09% 1-Year Est. Return
1WA
180 Wealth Advisors Federal Way, Washington $997M AUM 47.84% 1-Year Est. Return

PMG Family Office's HQL Position: Q2 2026 in Review

PMG Family Office increased its abrdn Life Sciences Investors (HQL) stake by 1.1% in Q2 2026, buying an estimated $4.43K and bringing the position to 23,312 shares worth $466K. The position accounts for 0.43% of the portfolio, ranked #76.

PMG Family Office first reported a position in HQL in Q3 2025 and has held it in 4 quarters since. 83 funds tracked by Wall St. Rank hold HQL as of Q2 2026.

  • PMG Family Office held 23,312 shares of abrdn Life Sciences Investors worth $466K as of Q2 2026.
  • PMG Family Office bought 251 abrdn Life Sciences Investors shares in Q2 2026, an estimated $4.43K.
  • abrdn Life Sciences Investors made up 0.43% of PMG Family Office's portfolio in Q2 2026, its #76 holding.
  • PMG Family Office first reported a position in abrdn Life Sciences Investors in Q3 2025 and has held it in 4 quarters since.
  • 83 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q2 2026.

Based on PMG Family Office's 13F filing for Q2 2026, filed 16 Jul 2026.